Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Kronos Bio, Inc. (KRON)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/07/2023 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 6,634 shares
@ $1.7523, valued at
$11.6k
|
|
| 07/07/2023 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 10,818 shares
@ $1.7523, valued at
$19k
|
|
| 07/07/2023 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 9,617 shares
@ $1.7523, valued at
$16.9k
|
|
| 04/24/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2023 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 6,291 shares
@ $1.7355, valued at
$10.9k
|
|
| 02/24/2023 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 10,153 shares
@ $1.7355, valued at
$17.6k
|
|
| 02/24/2023 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 9,026 shares
@ $1.7355, valued at
$15.7k
|
|
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/27/2022 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 43,550 shares
@ $0 |
|
| 07/27/2022 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 60,300 shares
@ $0 |
|
| 07/27/2022 |
4
| Kosacz Barbara (COO & General Counsel) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 53,600 shares
@ $0 |
|
| 06/29/2022 |
4
| Yang Taiyin (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 11,333 shares
@ $0
Granted 17,000 options to buy
@ $3.53, valued at
$60k
|
|
| 06/29/2022 |
4
| De Backer Marianne (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 11,333 shares
@ $0
Granted 17,000 options to buy
@ $3.53, valued at
$60k
|
|
| 06/29/2022 |
4
| Blunt Roshawn A. (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 34,000 options to buy
@ $3.53, valued at
$120k
|
|
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2022 |
4
| BISCHOFBERGER NORBERT W (President & CEO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 400,000 options to buy
@ $7.3, valued at
$2.9M
|
|
| 02/17/2022 |
4
| Kosacz Barbara (COO & General Counsel) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 53,600 shares
@ $0
Granted 80,000 options to buy
@ $7.08, valued at
$566.4k
|
|
| 02/17/2022 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 60,300 shares
@ $0
Granted 90,000 options to buy
@ $7.08, valued at
$637.2k
|
|
| 02/17/2022 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 43,550 shares
@ $0
Granted 65,000 options to buy
@ $7.08, valued at
$460.2k
|
|
| 02/17/2022 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 53,600 shares
@ $0
Granted 80,000 options to buy
@ $7.08, valued at
$566.4k
|
|
| 12/15/2021 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 11,212 shares
@ $12.363, valued at
$138.6k
Sold 174 shares
@ $12.8203, valued at
$2.2k
|
|
| 12/15/2021 |
4
| DiMartino Jorge (Chief Medical Officer & VP) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 16,152 shares
@ $12.363, valued at
$199.7k
Sold 250 shares
@ $12.8238, valued at
$3.2k
|
|
| 12/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/02/2021 |
4
| De Backer Marianne (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Bought 1,150 shares
@ $11.57, valued at
$13.3k
|
|
| 11/15/2021 |
4
| Blunt Roshawn A. (Director) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Granted 41,200 options to buy
@ $17.1, valued at
$704.5k
|
|
| 10/04/2021 |
4
| Dinsmore Christopher (Chief Scientific Officer) has filed a Form 4 on Kronos Bio, Inc.|
Txns:
| Sold 9,189 shares
@ $20.8069, valued at
$191.2k
Exercised 9,189 options to buy
@ $3.27, valued at
$30k
|
|
|
|
|